Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

US Patent 11413308 · Granted Aug 16, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and t2025
Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and t2024
Methods of treating a subject for pain2023
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolas2022
Methods and compositions for treating aging-associated impairments using CCR3-in2022
Methods and compositions for treating aging-associated impairments using CCR3-in2022
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolas2022
Methods of improving or accelerating postoperative recovery2021
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2021
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2021
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2021
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2021